Poland · Delayed Price · Currency is PLN Pharmena Statistics
Total Valuation
Pharmena has a market cap or net worth of PLN 36.31 million. The enterprise value is 36.20 million.
| Market Cap | 36.31M |
| Enterprise Value | 36.20M |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Pharmena has 11.14 million shares outstanding.
| Current Share Class | 11.14M |
| Shares Outstanding | 11.14M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.89% |
| Owned by Institutions (%) | 1.86% |
| Float | 3.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.85 |
| PB Ratio | 4.44 |
| P/TBV Ratio | 5.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 24.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.69, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.69 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.09 |
| Interest Coverage | -145.22 |
Financial Efficiency
Return on equity (ROE) is -31.51% and return on invested capital (ROIC) is -38.93%.
| Return on Equity (ROE) | -31.51% |
| Return on Assets (ROA) | -19.22% |
| Return on Invested Capital (ROIC) | -38.93% |
| Return on Capital Employed (ROCE) | -39.55% |
| Weighted Average Cost of Capital (WACC) | 7.00% |
| Revenue Per Employee | 208,714 |
| Profits Per Employee | -436,714 |
| Employee Count | 7 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 0.36 |
Taxes
In the past 12 months, Pharmena has paid 12,000 in taxes.
| Income Tax | 12,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.86% in the last 52 weeks. The beta is 0.50, so Pharmena's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -6.86% |
| 50-Day Moving Average | 3.14 |
| 200-Day Moving Average | 3.28 |
| Relative Strength Index (RSI) | 57.76 |
| Average Volume (20 Days) | 5,903 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharmena had revenue of PLN 1.46 million and -3.06 million in losses. Loss per share was -0.27.
| Revenue | 1.46M |
| Gross Profit | 1.21M |
| Operating Income | -3.34M |
| Pretax Income | -3.05M |
| Net Income | -3.06M |
| EBITDA | -3.30M |
| EBIT | -3.34M |
| Loss Per Share | -0.27 |
Balance Sheet
The company has 421,000 in cash and 314,000 in debt, with a net cash position of 107,000 or 0.01 per share.
| Cash & Cash Equivalents | 421,000 |
| Total Debt | 314,000 |
| Net Cash | 107,000 |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 8.17M |
| Book Value Per Share | 0.73 |
| Working Capital | 6.25M |
Cash Flow
In the last 12 months, operating cash flow was -3.04 million and capital expenditures -456,000, giving a free cash flow of -3.50 million.
| Operating Cash Flow | -3.04M |
| Capital Expenditures | -456,000 |
| Depreciation & Amortization | 36,000 |
| Net Borrowing | -90,000 |
| Free Cash Flow | -3.50M |
| FCF Per Share | -0.31 |
Margins
Gross margin is 82.55%, with operating and profit margins of -228.61% and -209.24%.
| Gross Margin | 82.55% |
| Operating Margin | -228.61% |
| Pretax Margin | -208.42% |
| Profit Margin | -209.24% |
| EBITDA Margin | -226.15% |
| EBIT Margin | -228.61% |
| FCF Margin | n/a |
Dividends & Yields
Pharmena does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -8.42% |
| FCF Yield | -9.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |